Literature DB >> 19366491

Surveillance for severe community-associated methicillin-resistant Staphylococcus aureus infection.

P Wiersma1, M Tobin D'Angelo, W R Daley, J Tuttle, K E Arnold, S M Ray, J L Ladson, S N Bulens, C L Drenzek.   

Abstract

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has rapidly emerged in the USA as a cause of severe infections in previously healthy persons without traditional risk factors. We describe the epidemiology of severe CA-MRSA disease in the state of Georgia, USA and analyse the risk of death associated with three different clinical syndromes of CA-MRSA disease - pneumonia, invasive disease, and skin and soft-tissue infections (SSTIs). A total of 1670 cases of severe CA-MRSA disease were reported during 2005-2007. The case-fatality rate was 3.4%; sex and race of fatal and non-fatal cases did not differ significantly. While CA-MRSA pneumonia and invasive disease were less common than SSTIs, they were about 15 times more likely to result in death [risk ratio 16.69, 95% confidence interval (CI) 10.28-27.07 and 13.98, 95% CI 7.74-25.27, respectively]. When controlling for age and the presence of other clinical syndromes the odds of death in patients manifesting specific severe CA-MRSA syndromes was highest in those with pneumonia (odds ratio 11.34). Possible risk factors for severe CA-MRSA SSTI and pneumonia included the draining of lesions without medical assistance and an antecedent influenza-like illness.

Entities:  

Mesh:

Year:  2009        PMID: 19366491     DOI: 10.1017/S0950268809002490

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

1.  Staphylococcus aureus YoeB homologues inhibit translation initiation.

Authors:  Satoshi Yoshizumi; Yonglong Zhang; Yoshihiro Yamaguchi; Liang Chen; Barry N Kreiswirth; Masayori Inouye
Journal:  J Bacteriol       Date:  2009-07-06       Impact factor: 3.490

2.  Use of Corynebacterium pseudodiphtheriticum for elimination of Staphylococcus aureus from the nasal cavity in volunteers exposed to abnormal microclimate and altered gaseous environment.

Authors:  N V Kiryukhina; V G Melnikov; A V Suvorov; Yu A Morozova; V K Ilyin
Journal:  Probiotics Antimicrob Proteins       Date:  2013-12       Impact factor: 4.609

Review 3.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 4.  Resistant pathogens, fungi, and viruses.

Authors:  Christopher A Guidry; Sara A Mansfield; Robert G Sawyer; Charles H Cook
Journal:  Surg Clin North Am       Date:  2014-10-03       Impact factor: 2.741

5.  Higher seasonal temperature enhances the occurrence of methicillin resistance of Staphylococcus aureus in house flies (Musca domestica) under hospital and environmental settings.

Authors:  Md Abdus Sobur; Md Saiful Islam; Zobayda Farzana Haque; Ebiowei Samuel F Orubu; Antonio Toniolo; Md Abu Choudhury; Md Tanvir Rahman
Journal:  Folia Microbiol (Praha)       Date:  2021-09-26       Impact factor: 2.099

6.  Seasonality of MRSA infections.

Authors:  Leonard A Mermel; Jason T Machan; Stephen Parenteau
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

7.  Incidence of methicillin-resistant Staphylococcus aureus infection in a children's hospital in the Washington metropolitan area of the United States, 2003 - 2010.

Authors:  Xiaoyan Song; Jonathan Cogen; Nalini Singh
Journal:  Emerg Microbes Infect       Date:  2013-10-09       Impact factor: 7.163

8.  Incidence of Community-associated Methicillin-resistant Staphylococcus aureus Infections in a Regional Hospital.

Authors:  Hidenobu Kawabata; Manabu Murakami; Kengo Kisa; Masaji Maezawa
Journal:  J Rural Med       Date:  2011

9.  The use of the temporal scan statistic to detect methicillin-resistant Staphylococcus aureus clusters in a community hospital.

Authors:  Meredith C Faires; David L Pearl; William A Ciccotelli; Olaf Berke; Richard J Reid-Smith; J Scott Weese
Journal:  BMC Infect Dis       Date:  2014-07-08       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.